Immunosuppression for Parkinson's disease - a new therapeutic strategy?
Video page · May 30, 2023
Caroline Williams-Gray
We use cookies for analytics.
Gastroenterology, Clinical Pharmacology, Pharmacology and seminar by Dr David Bulmer, Department of Pharmacology, University of Cambridge
Hosted by Cambridge Neuro
Tuesday 15:00–16:10 London (GMT+0)
Recording available
Chronic pain is a leading cause of morbidity, common to patients with gastrointestinal diseases such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Most pain killers are largely ineffective against this type of pain or restricted for use in these patients due to gut related complications and risk of addition. A significant unmet clinical need therefore exists to develop novel non-opioid based visceral analgesics.